Related Experiment Video
Updated: Jun 30, 2025
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Cutaneous melanoma and purinergic modulation by phenolic compounds
Geórgia de Carvalho Braga1, João Victor Coiado1, Vitória Capelli de Melo1
1Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.
Abstract:
Cutaneous melanoma is a complex pathology that still has only treatments that lack efficiency and offer many adverse effects. Due to this scenario emerges the need to analyze other possible treatments against this disease, such as the effect of phenolic compounds. These substances have proven antitumor effects, but still have not been fully explored as a form of therapy to combat melanoma. Also, the purinergic receptors, along with its system molecules, take part in the formation of tumors from many pathways, such as the actions of ectoenzymes and receptors activity, especially P2Rs family, and are formed by structures that can be modulated by the phenolic compounds. Therefore, more studies have to be made with the aim of explaining the purinergic system activity in carcinogenesis of cutaneous melanoma and the effects of its modulation by phenolic compound, in order to enable the development of new therapies to combat this aggressive and feared cancer.
Insights
Phenolic compounds show potential as novel melanoma treatments by targeting the purinergic system. Further research is needed to explore their therapeutic efficacy against this aggressive skin cancer.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Cutaneous melanoma treatments are limited by efficacy and adverse effects.
- Phenolic compounds possess demonstrated antitumor properties.
- The purinergic system, including P2Rs and ectoenzymes, plays a role in tumor formation.
Purpose of the Study:
- To investigate the potential of phenolic compounds as a therapeutic strategy for cutaneous melanoma.
- To explore the role of the purinergic system in melanoma carcinogenesis.
- To examine the modulatory effects of phenolic compounds on the purinergic system in melanoma.
Main Methods:
- Analysis of phenolic compounds' effects on melanoma cells.
- Investigation of purinergic receptor (P2R) activity in melanoma.
- Exploration of ectoenzyme function in melanoma carcinogenesis.
Main Results:
- Phenolic compounds exhibit antitumor effects relevant to melanoma.
- The purinergic system is implicated in melanoma development.
- Potential interactions between phenolic compounds and purinergic signaling identified.
Conclusions:
- Phenolic compounds represent a promising avenue for novel melanoma therapies.
- Understanding purinergic system modulation by phenolics is crucial for drug development.
- Further studies are warranted to develop effective melanoma treatments targeting this pathway.
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:31The Intrinsic Apoptotic Pathway
02:23Abnormal Proliferation
01:19Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...